- Chemotherapeutic Engineering: Vitamin E TPGS-Emulsified Nanoparticles of Biodegradable Polymers Realized Sustainable Paclitaxel Chemotherapy for 168 h in vivo

2014 ◽  
pp. 180-195
2007 ◽  
Vol 62 (23) ◽  
pp. 6641-6648 ◽  
Author(s):  
Si-Shen Feng ◽  
Lingyun Zhao ◽  
Zhiping Zhang ◽  
Gajadhar Bhakta ◽  
Khin Yin Win ◽  
...  

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Raghuvir H. Gaonkar ◽  
Soumya Ganguly ◽  
Saikat Dewanjee ◽  
Samarendu Sinha ◽  
Amit Gupta ◽  
...  

RSC Advances ◽  
2015 ◽  
Vol 5 (66) ◽  
pp. 53671-53686 ◽  
Author(s):  
Lakhvir Kaur ◽  
Subheet Kumar Jain ◽  
Kanwaldeep Singh

Enhanced skin permeation and deposition potential of nanogel containing Vitamin E TPGS.


2017 ◽  
Vol 2017 ◽  
pp. 1-10 ◽  
Author(s):  
Sanaul Mustafa ◽  
V. Kusum Devi ◽  
Roopa S. Pai

Kanamycin sulphate (KS) is a Mycobacterium tuberculosis protein synthesis inhibitor. Due to its intense hydrophilicity, KS is cleared from the body within 8 h. KS has a very short plasma half-life (2.5 h). KS is used in high concentrations to reach the therapeutic levels in plasma, which results in serious nephrotoxicity/ototoxicity. To overcome aforementioned limitations, the current study aimed to develop KS loaded PLGA-Vitamin-E-TPGS nanoparticles (KS-PLGA-TPGS NPs), to act as an efficient carrier for controlled delivery of KS. To achieve a substantial extension in blood circulation, a combined design, affixation of polyethylene glycol (PEG) to KS-PLGA-TPGS NPs and adsorption of water-soluble chitosan (WSC) (cationic deacetylated chitin) to particle surface, was raised for surface modification of NPs. Surface modified NPs (KS-PEG-WSC NPs) were prepared to provide controlled delivery and circulate in the bloodstream for an extended period of time, thus minimizing dosing frequency. In vivo pharmacokinetics and in vivo biodistribution following intramuscular administration were investigated. NPs surface charge was close to neutral +3.61 mV and significantly affected by the WSC coating. KS-PEG-WSC NPs presented striking prolongation in blood circulation, reduced protein binding, and long drew-out the blood circulation half-life with resultant reduced kidney sequestration vis-à-vis KS-PLGA-TPGS NPs. The studies, therefore, indicate the successful formulation development of KS-PEG-WSC NPs with reduced frequency of dosing of KS indicating low incidence of nephrotoxicity/ototoxicity.


2015 ◽  
Vol 24 (2) ◽  
pp. 161-168 ◽  
Author(s):  
Xudong Cheng ◽  
Hongmei Yan ◽  
Xiaobin Jia ◽  
Zhenhai Zhang

Sign in / Sign up

Export Citation Format

Share Document